SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Zecevic, R D
Right arrow Articles by Karadaglic, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zecevic, R D
Right arrow Articles by Karadaglic, D
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Skin lesions - an indicator of disease activity in systemic lupus erythematosus?

R D Zecevic

Department of Dermatology, Military Medical Academy, Crnotravska 17, 11002 Belgrade, Yugoslavia; brankaz{at}eunet.yu

D Vojvodic

Department of Dermatology, Military Medical Academy, Belgrade, Yugoslavia

B Ristic

M D Pavlovic

Institute of Medical Research, Military Medical Academy, Belgrade, Yugoslavia

D Stefanovic

Department of Rheumatology and Clinical Immunology, Military Medical Academy, Belgrade, Yugoslavia

D Karadaglic

Institute of Medical Research, Military Medical Academy, Belgrade, Yugoslavia

Cutaneous manifestations have great diagnostic value for systemic lupus erythematosus (SLE). In this study we tried to establish a correlation between lupus erythematosus LE-specific and LE-nonspecific cutaneous lesions and disease activity measured by the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). Sixty-six patients with SLE were evaluated. They were divided into three groups having: (1) only LE-specific lesions (38 or 58.46%); (2) only LE-nonspecific lesions (4 or 6.15%); and (3) both types of lesions (23 or 35.38%). Results were analyzed using the Student t-test.

Patients with LE-nonspecific skin manifestations had significantly increased disease activity compared to those with only LE-specific lesions. The number of different skin lesion types also correlated with disease activity. It was significantly increased in a group with three different types of lesion, either specific or nonspecific. Patients with only one type of lesion had mild disease. An intermediate disease activity was found in the group with two different lesion types.

Lupus-specific skin manifestations serve primarily as an important diagnostic clue. In conclusion, patients with LE-nonspecific lesions have significantly more active SLE than those with LE-specific lesions and may therefore require more intensive therapy and disease monitoring.

Key Words: systemic lupus erythematosus • skin lesions • SLEDAI

Lupus, Vol. 10, No. 5, 364-367 (2001)
DOI: 10.1191/096120301675962535


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
LupusHome page
Y. Bae, S-J. Yun, J-B. Lee, S-J. Kim, Y. Won, and S-C. Lee
A clinical and epidemiological study of lupus erythematosus at a tertiary referral dermatology clinic in Korea
Lupus, December 1, 2009; 18(14): 1320 - 1326.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
G Bertsias, J P A Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, J Font, I M Gilboe, F Houssiau, T Huizinga, et al.
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
Ann Rheum Dis, February 1, 2008; 67(2): 195 - 205.
[Abstract] [Full Text] [PDF]



Advertisement